Improving Translational Medicine by Humanization of Mouse Models

Speaker Dr Mark Moore, PhD CEO of GemPharmatech discusses at Fierce JPM Week 2022, GemPharmatech’s mission to improve translation medicine through humanization of genetically engineered mouse models.

 

For more information, please contact sales@atlantisbioscience.com

Tags: #oncology, animalmodels, drugdevelopment, humanisedimmunecheckpointinhibitor, immunodeficient, immunooncology, preclinicaloncology, translationalmedicine